Lightnews — Scholar-powered news

Jen L, PhD

@drjkyl.bsky.social

2.9K followers 16K following 340 posts

Executive Editor/Team Lead Open Access Science & Medicine Journals Sage Publishing
Opinions = mine

http://linkedin.com/in/jlovick-editor

#oncology #cancerresearch #medicine #biology #cardiology #neurology #microbiology #publichealth #healthcare

Posts Replies Media Videos

Pinned

Jen L, PhD @drjkyl.bsky.social · Feb 21

Introduction - PhD working in academic publishing, lead a team of amazing Managing Editors that support @sagepub.com @journals.sagepub.com 's Open Access Biomedical Journals. I'll be sharing recent articles from our journals that I find interesting. Happy to connect with researchers! 📖🔬🧪💊⚕️

Reposted by Jen L, PhD

Lingling Tian

@linglingtian.bsky.social

New review highlights how PSMA‑targeted radioligand therapy, including 177Lu‑PSMA‑617 and emerging isotopes like 225Ac/161Tb, is reshaping advanced prostate cancer care. Combination strategies and precision dosimetry point to a rapidly evolving future.
🔗 buff.ly/WKhPij0
#ProstateCancer #RLT #PSMA

February 13, 2026 at 8:15 AM

Jen L, PhD

@drjkyl.bsky.social

From schizophrenia to dementia: Is Cobenfy a potential treatment for behavioral and psychological symptoms of dementia?

Journal of International Medical Research
@journals.sagepub.com

journals.sagepub.com/doi/10.1177/...

#neuropsychiatric #pharmacology #medicine #research #openaccess

February 12, 2026 at 9:38 PM

Jen L, PhD

@drjkyl.bsky.social

Clinical efficacy and safety of endoscopic ultrasound-guided ablation therapies for pancreatic neuroendocrine tumors: a systematic review and meta-analysis
@tagastroenterol.bsky.social
@journals.sagepub.com

journals.sagepub.com/doi/10.1177/...

#pancreaticcancer #raretumors #oncology #openaccess

February 12, 2026 at 9:36 PM

Jen L, PhD

@drjkyl.bsky.social

Efficacy and safety of glucagon-like peptide-1 receptor agonists in Parkinson’s disease: a systematic review and meta-analysis of randomized placebo-controlled clinical trials
@taneuroldisord.bsky.social
@journals.sagepub.com

journals.sagepub.com/doi/10.1177/...

#GLP-1 #neurology #openaccess

February 12, 2026 at 9:34 PM

Jen L, PhD

@drjkyl.bsky.social

Enhancing Brain Tumor Classification and Generalization Using DDPM-Generated MRI, Mutual Information and Ensemble Learning
@tcrtcancer.bsky.social
@journals.sagepub.com

journals.sagepub.com/doi/10.1177/...

#artificialintelligence #cancerresearch #oncology #openaccess

February 12, 2026 at 9:30 PM

Jen L, PhD

@drjkyl.bsky.social

Enhancing early prediction of pathological complete response in breast cancer using attention-based convolutional neural networks in digital pathology

Digital Health
@journals.sagepub.com

journals.sagepub.com/doi/10.1177/...

#chemotherapy #cancertreatment #cancerresearch #oncology #openaccess

February 12, 2026 at 8:07 PM

Jen L, PhD

@drjkyl.bsky.social

What Peroxisomes (Don’t) do to Mitochondria

Contact: The Journal of Inter-Organelle Communication
@contactctc.bsky.social
@journals.sagepub.com

journals.sagepub.com/doi/10.1177/...

#membrane #ROS #metabolism #research #openaccess

February 12, 2026 at 8:04 PM

Jen L, PhD

@drjkyl.bsky.social

Temporal dynamics of mesenchymal stem cell administration influence immune modulation in a 4T1 breast cancer model
@celltransplant1992.bsky.social
@journals.sagepub.com

journals.sagepub.com/doi/10.1177/...

#celltransplantation #regenerativemedicine #immunology #openaccess

February 12, 2026 at 8:01 PM

Jen L, PhD

@drjkyl.bsky.social

Balancing Efficacy and Toxicity in Salvage Brachytherapy and SBRT for Radio-Recurrent Prostate Cancer: Insights Beyond the UroGEC Review
@tcrtcancer.bsky.social
@journals.sagepub.com

journals.sagepub.com/doi/10.1177/...

#radiotherapy #cancertreatment #oncology #openaccess

February 12, 2026 at 7:58 PM

Reposted by Jen L, PhD

Natural Product Communications

@naturalproductcomm.bsky.social

Top Read Papers on Natural Product Communications - February 2026

💡3. Unlocking the Potential of Cucurbitaceae Seed Oils: A Narrative Review on Phytochemical, Pharmacological, and Biotechnological Applications

journals.sagepub.com/doi/10.1177/...

February 12, 2026 at 9:46 AM

Reposted by Jen L, PhD

Technology in Cancer Research & Treatment (IF 2.8)

@tcrtcancer.bsky.social

New in @tcrtcancer.bsky.social: Portable Electrical Impedance Prescreening for Breast tissue suspicious for malignancy: Model Optimization and Clinical Performance of the Julieta Device in a Multicenter Cross-Sectional Study in Colombia

journals.sagepub.com/doi/full/10....

#SalvaHealth #OncoDaily

Sage Journals: Discover world-class research

Subscription and open access journals from Sage, the world's leading independent academic publisher.

journals.sagepub.com

February 12, 2026 at 2:28 PM

Reposted by Jen L, PhD

Therapeutic Advances in Infectious Disease

@tainfdis.bsky.social

In this systematic review (29 studies), mNGS outperformed culture for spinal infections with broader pathogen detection,higher sensitivity,faster turnaround⏱️ Challenges remain: cost & distinguishing colonization from infection.
journals.sagepub.com/doi/full/10....

February 12, 2026 at 3:15 PM

Reposted by Jen L, PhD

Therapeutic Advances in Medical Oncology

@tamedoncol.bsky.social

Real‑world, 8‑year multicancer study of lenvatinib shows manageable long‑term use across DTC, AdCC, HCC & EC. Notably, BMI declined during treatment (p=0.045), highlighting the need for closer monitoring in low‑BMI patients.
🔗 buff.ly/Ckygpuz
#Lenvatinib

February 11, 2026 at 6:04 PM

Reposted by Jen L, PhD

Therapeutic Advances in Neurological Disorders

@taneuroldisord.bsky.social

New Case Report online!
Spinocerebellar ataxia type 3 (SCA3) masquerading as atypical parkinsonism?
🔎The findings underscore the importance of genetic testing in atypical parkinsonism and the need for personalized deep-brain stimulation strategies in SCA3.
journals.sagepub.com/doi/full/10....

February 6, 2026 at 1:38 PM

Reposted by Jen L, PhD

Lingling Tian

@linglingtian.bsky.social

Early NSCLC is entering a new era. Broad NGS profiling now identifies actionable mutations that guide adjuvant EGFR/ALK‑targeted therapy, influence immunotherapy decisions, and support ctDNA‑based MRD monitoring.
🔗 buff.ly/FKnT16B
#NSCLC #LungCancer #NGS #ctDNA #MRD #PrecisionOncology

February 7, 2026 at 8:15 AM

Reposted by Jen L, PhD

Therapeutic Advances in Medical Oncology

@tamedoncol.bsky.social

Review on pregnancy & breast cancer in young women: PrBC vs PPBC distinctions, chemo during pregnancy (incl. taxanes after 1st trimester), POSITIVE trial on ET interruption, and fertility preservation gaps for targeted agents.
🔗 buff.ly/ZDZelh2
#BreastCancer #YWBC

February 7, 2026 at 6:03 PM

Reposted by Jen L, PhD

Natural Product Communications

@naturalproductcomm.bsky.social

Top Read Papers on Natural Product Communications - February 2026

💡2. Therapeutic Value of Plant Saponins, Challenges and Opportunities: A Review

journals.sagepub.com/doi/10.1177/...

February 9, 2026 at 9:26 AM

Reposted by Jen L, PhD

Therapeutic Advances in Neurological Disorders

@taneuroldisord.bsky.social

New research online!
What is the real-world effectiveness and tolerability of #lasmiditan in the acute treatment of #migraine?

journals.sagepub.com/doi/full/10....

February 9, 2026 at 3:01 PM

Reposted by Jen L, PhD

Lingling Tian

@linglingtian.bsky.social

A new review examines how gut microbiota influence response and toxicity to neoadjuvant chemoradiotherapy in LARC. Beneficial species (e.g., Akkermansia, Alistipes) may enhance treatment effect, while pathogens like F. nucleatum may drive resistance.
🔗 buff.ly/PefDIka

February 10, 2026 at 8:15 AM

Reposted by Jen L, PhD

Therapeutic Advances in Neurological Disorders

@taneuroldisord.bsky.social

Is intravenous immunoglobulin (IVIG) therapy effective in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) patients with #diabetes mellitus?

Check out this new prospective study by Samir Macwan and colleagues to find out more:
journals.sagepub.com/doi/full/10....

February 10, 2026 at 11:12 AM

Jen L, PhD

@drjkyl.bsky.social

Prognostic value of ctDNA-derived maximum somatic allele frequency in patients with metastatic gastric cancer
@tamedoncol.bsky.social
@journals.sagepub.com

journals.sagepub.com/doi/10.1177/...

#biomarker #cancerresearch #prognosis #oncology #openaccess

February 9, 2026 at 10:00 PM

Jen L, PhD

@drjkyl.bsky.social

Transfusion-induced hemolysis in warm autoimmune hemolytic anemia with autoantibodies that have anti-e specificity: a case report and systematic review of the literature

Therapeutic Advances in Hematology
@journals.sagepub.com

journals.sagepub.com/doi/10.1177/...

#medicine #treatment #openaccess

February 9, 2026 at 9:58 PM

Jen L, PhD

@drjkyl.bsky.social

Applicability of colon capsule endoscopy in FIT-positive individuals unable or unwilling to undergo colonoscopy within a colorectal cancer screening programme

Therapeutic Advances in Gastrointestinal Endoscopy
@journals.sagepub.com

journals.sagepub.com/doi/10.1177/...

#oncology #openaccess